SCHEMBL1010647

SCHEMBL1010647

Oc1ccccc1N1CCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.60
HTT P42858 2/20 0.60
KEAP1 Q14145 1/20 0.54
MAPK1 P28482 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 1/20 0.51
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TLR9 Q9NR96 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
DRD4 P21917 1/20 0.49
NR1I2 O75469 1/20 0.49
SMARCA2 P51531 1/20 0.49
SMARCA4 P51532 1/20 0.49
PBRM1 Q86U86 1/20 0.49
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1008507 0.98 GAA (0.58) GAAHTTKEAP1MAPK1MEN1
Bromide SCHEMBL27386790 0.96 GAA (0.56) GAAHTTKEAP1MAPK1MEN1
SCHEMBL3043141 0.95 GAA (0.60) GAAHTTKEAP1MAPK1MEN1
SCHEMBL11120307 0.90 GAA (0.70) GAAHTTMAPK1MEN1KMT2A
SCHEMBL4019882 0.90 GAA (0.70) GAAHTTMAPK1MEN1KMT2A
SCHEMBL30561226 0.87 GAA (0.53) GAAHTTKEAP1MAPK1MEN1
SCHEMBL26219177 0.82 MAPK1 (0.70) GAAKEAP1MAPK1NPC1MAPT
SCHEMBL31321556 0.80 ADRB1 (0.62) GAAHTTMAPTSMARCA2SMARCA4
SCHEMBL531748 0.80 ADRB1 (0.62) GAAHTTMAPTSMARCA2SMARCA4
SCHEMBL1308333 0.80 ADRA2C (0.60) GAAHTTMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12187911-B2 Method for preparing water-soluble acrylic-modified phenolic-modified epoxy resin, water-soluble acrylic-modified phenolic-modified epoxy resin prepared thereby, and aqueous coating composition comprising same SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) 2025-01-07 US claimed
US-20240117213-A1 METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) 2024-04-11 US claimed
WO-2021075800-A1 METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME 삼화페인트공업주식회사 2021-04-22 WO claimed
CN-102993211-B Azacyclo-substituted benzo spirooxazine photochromic compound and preparation method thereof TIANJIN FORESEEN TECHNOLOGY CO LTD 2015-04-01 CN claimed
US-20250216782-A1 MASKING PROCESS USING SWITCHABLE POLYMER TOKYO ELECTRON LTD (JP) 2025-07-03 US disclosed
US-12187911-B2 Method for preparing water-soluble acrylic-modified phenolic-modified epoxy resin, water-soluble acrylic-modified phenolic-modified epoxy resin prepared thereby, and aqueous coating composition comprising same SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) 2025-01-07 US disclosed
US-20240117213-A1 METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) 2024-04-11 US disclosed
WO-2021154966-A1 COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS KAMARI PHARMA LTD. (IL) 2021-08-05 WO disclosed
WO-2021075800-A1 METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME 삼화페인트공업주식회사 2021-04-22 WO disclosed
CN-108586424-B Benzylation synthesis method of phenol compounds 青岛农业大学 2020-07-21 CN disclosed
US-9856208-B2 Method for producing an arene with an aromatic C—N bond ortho to an aromatic C—O bond THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2018-01-02 US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 US disclosed
EP-0927161-A1 SUBSTITUTED CYCLIC AMINE METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-07-07 EP disclosed
WO-1998008815-A1 SUBSTITUTED CYCLIC AMINE METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1998-03-05 WO disclosed
CN-1169736-A Catalyst for olefin polymerization ASAHI CHEMICAL IND (JP) 1998-01-07 CN disclosed
EP-0798313-A1 OLEFIN POLYMERIZATION CATALYST Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1997-10-01 EP disclosed
CN-1155679-A Image forming process FUJI PHOTO FILM CO LTD (JP) 1997-07-30 CN disclosed
EP-0172321-B1 SQUARYLIUM CHARGE GENERATING DYE AND ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR International Business Machines Corporation (US) 1987-11-19 EP disclosed
US-4677045-A NON-MUTAGENIC INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1987-06-30 US disclosed
EP-0172321-A2 Squarylium charge generating dye and electrophotographic photoconductor International Business Machines Corporation (US) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND AOX1, NOX4, NOXO1 GAA 2696/4885HTT 1540/4885KEAP1 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.